Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sanjar Sultanov"'
Autor:
Sanjar Sultanov, Komila Negmatova, Soyibjon Negmatov, Nodira Abed, Madina Babakhanova, Muxabat Matsharipova, Gulshan Valiyeva, Olloberdi Madraximov, Nilufar Umirova, Muxiba Babakhanova, Azizbek Nasriddinov
Publikováno v:
2021 ASIA-PACIFIC CONFERENCE ON APPLIED MATHEMATICS AND STATISTICS.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1c245c7f5c191153205932cc58bcca4
https://doi.org/10.1063/5.0090796
https://doi.org/10.1063/5.0090796
Autor:
Jamshid Gadoev, Laziz Turaev, Sanjar Sultanov, Nargiza Parpieva, Kozim Mukhamedov, Rafis Rakhmatulin
Publikováno v:
Paediatric respiratory infection and immun..
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc7a87168e6ed83cf0bc064e2268b37d
https://doi.org/10.1183/13993003.congress-2021.pa3155
https://doi.org/10.1183/13993003.congress-2021.pa3155
Autor:
Nargiza Parpieva, Sanjar Sultanov, Zuhriddin Nuriddinov, Mukhabbat Djurabaeva, Ekaterina Anvarova, Kazim Mukhamedov
Publikováno v:
Tuberculosis.
Introduction: In Uzbekistan, the incidence of tuberculosis (TB) decreasing, from 52 per 100 thousand people in 2011 to 42 in 2018. In recent years, cases of detection of NTM have begun to be recorded. Aim and Objectives: To analyze the frequency of o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e83c6654c9a0038a9db6b9838e423764
https://doi.org/10.1183/13993003.congress-2020.1451
https://doi.org/10.1183/13993003.congress-2020.1451
Autor:
Dilyara Nabirova, Ajay M. V. Kumar, Zayniddin Sayfutdinov, Jamshid Gadoev, Laziz Turaev, Nargiza Parpieva, Sevak Alaverdyan, Sanjar Sultanov
Publikováno v:
International Journal of Environmental Research and Public Health, Vol 18, Iss 2965, p 2965 (2021)
International Journal of Environmental Research and Public Health
Volume 18
Issue 6
International Journal of Environmental Research and Public Health
Volume 18
Issue 6
Tuberculosis patients “resistant to isoniazid and susceptible to rifampicin (Hr-TB)” remain neglected, despite a high burden and poor outcomes. The World Health Organization (WHO) recommends a 6 month regimen consisting of levofloxacin, rifampici
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1448c84760143f48e938bc827528716f
https://doi.org/10.3390/ijerph18062965
https://doi.org/10.3390/ijerph18062965
Publikováno v:
Tuberculosis.
Objective: to research the compliance of patients with multidrug-resistant pulmonary tuberculosis (MDR TB) based on the brief medication questionnaire and Morisky-Green Test (MGT). Research methods and Findings: A total of 65 compliant patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c247bb58f7390026e5323e4532e18ec
https://doi.org/10.1183/1393003.congress-2017.pa2702
https://doi.org/10.1183/1393003.congress-2017.pa2702